PubHawk
June 2024 PMID 38804216

Review of the Ticagrelor Trials Evidence Base.

Grace C Herron, Eric R Bates

Full text PDF Download social card

Mentions

37
Peak: 17 in May 2024
across 4 sources since May 2024

Extended reach

192,541
potential audience

Total likes

145

Video views

1,133

Mentions per month

May 2024 – Jul 2025

Where it's discussed

  • X / Twitter29 posts
  • Facebook3 posts
  • News3 articles
  • YouTube2 videos

AI synopsis

What people are saying

Several comments highlight the extensive and conflicting nature of the evidence base on ticagrelor, such as references to comprehensive clinical trials and citations of contrarian views. Tone varies from neutral acknowledgment to slight enthusiasm, with phrases like 'nice to see' and mentions of citations indicating recognition but not deep engagement. This suggests a moderate overall perception of importance and interest, centered on the review's scope rather than its conclusions.

AgreementNeither agree nor disagree

The discussions are mixed, with some recognizing the breadth of research but also pointing to conflicting data, indicating neither full endorsement nor outright disagreement.

InterestModerate interest

People show modest interest, reflected in comments that acknowledge the review’s comprehensiveness and mention citations, but without deep analysis.

EngagementModerate engagement

The engagement appears surface-level, with mentions of the article and some appreciation for citations or the review's scope, rather than detailed critique or exploration.

ImpactNeutral impact

Overall, the social discussions suggest a moderate perception of impact—awareness exists, but there's no strong indication that these posts view the review as transformative or highly influential.

Abstract in brief

  • Ticagrelor is a widely used medication for preventing blood clots in patients with conditions like acute coronary syndromes, certain strokes, and transient ischemic attacks, with clinical trials showing its safety and effectiveness.
  • The review compares the results of major trials involving ticagrelor, clopidogrel, and prasugrel, highlighting how ticagrelor's benefits vary depending on patient characteristics, treatment duration, and specific medical indications.
  • The purpose of the review is to organize the extensive research on ticagrelor, identify areas where data agrees or conflicts, and pinpoint gaps that need further investigation to optimize antiplatelet therapy.]
Read the full abstract

Top posts

Most liked on X and Bluesky
The Heart
@ZHeart11768530 · X

May 31, 2024 · 84 likes · 25 shares · 32,814 followers View post →
JAHA
@JAHA_AHA · X

The ticagrelor evidence base is large, growing, and conflicting. This #AHAJournals #Review summarizes the major clinical trials data. https://t.co/SMMf0x6trf https://t.co/kJ4vt93Brf

Jun 20, 2024 · 22 likes · 6 shares · 31,349 followers View post →
SABOURETCardiologist
@SABOURETCardio · X

Nice to see that "our contrarian view" has been cited in this article : Review of the #Ticagrelor Trials Evidence Base | Journal of the American Heart Association https://t.co/GqtzjAjefi

May 30, 2024 · 11 likes · 2 shares · 31,172 followers View post →
Rk Jain
@drrkhyd · X

Review of the Ticagrelor Trials Evidence Base | Journal of the American Heart Association https://t.co/OyVAzt1EMY

Jun 1, 2024 · 1 like · 1 share · 682 followers View post →
Gautam
@sharma14828 · X

RT @ZHeart11768530:

May 31, 2024 · 25 shares · 37,773 followers View post →
The Heart
@ZHeart11768530 · X

RT @SABOURETCardio: Nice to see that "our contrarian view" has been cited in this article : Review of the #Ticagrelor Trials Evidence Base…

May 30, 2024 · 2 shares · 32,814 followers View post →

All mentions

William Baker
@wbaker0531 · X

RT @JAHA_AHA: The ticagrelor evidence base is large, growing, and conflicting. This #AHAJournals #Review summarizes the major clinical tria…

Jun 20, 2024 · 6 shares · 272 followers View post →
JAHA
@JAHA_AHA · X

The ticagrelor evidence base is large, growing, and conflicting. This #AHAJournals #Review summarizes the major clinical trials data. https://t.co/SMMf0x6trf https://t.co/kJ4vt93Brf

Jun 20, 2024 · 22 likes · 6 shares · 31,349 followers View post →
Maria Dolores
@MariaDo58618045 · X

RT @ZHeart11768530:

Jun 1, 2024 · 25 shares · 18 followers View post →
Oscar Aspiazu Segovia. MD. ESP. MFYC| MsC.MPH
@opolito8514 · X

RT @ZHeart11768530:

Jun 1, 2024 · 25 shares · 283 followers View post →
Linus fighter
@linus_us · X

RT @ZHeart11768530:

Jun 1, 2024 · 25 shares · 12 followers View post →
Dr Tusshar bhatti
@tusshar_dr · X

RT @drrkhyd: Review of the Ticagrelor Trials Evidence Base | Journal of the American Heart Association https://t.co/OyVAzt1EMY

Jun 1, 2024 · 1 share · 21 followers View post →
Antonio Antonucci
@pasquiz_85 · X

RT @ZHeart11768530:

Jun 1, 2024 · 25 shares · 218 followers View post →
Antonella degani
@Antonelladegan3 · X

RT @ZHeart11768530:

Jun 1, 2024 · 25 shares · 759 followers View post →
Natsu_85
@NMtjj85 · X

RT @ZHeart11768530:

Jun 1, 2024 · 25 shares · 40 followers View post →
ALKINDY Abdulrhman
@Abdul_alkindy · X

RT @ZHeart11768530:

Jun 1, 2024 · 25 shares · 829 followers View post →
Just Z
@ZSYouSoFunny · X

RT @ZHeart11768530:

Jun 1, 2024 · 25 shares · 426 followers View post →
Rk Jain
@drrkhyd · X

Review of the Ticagrelor Trials Evidence Base | Journal of the American Heart Association https://t.co/OyVAzt1EMY

Jun 1, 2024 · 1 like · 1 share · 682 followers View post →
Rafael E. Aguirre Q.
@drlitoaguirre1 · X

RT @ZHeart11768530:

May 31, 2024 · 25 shares · 3,069 followers View post →
Carlos Alvarez
@CarlosAlvarezDM · X

RT @ZHeart11768530:

May 31, 2024 · 25 shares · 660 followers View post →
Chidambara .ML.
@chidambara09 · X

RT @ZHeart11768530:

May 31, 2024 · 25 shares · 11,713 followers View post →
Tenich
@Marktenich · X

RT @ZHeart11768530:

May 31, 2024 · 25 shares · 339 followers View post →
ملاذ الطير
@funhero1 · X

RT @ZHeart11768530:

May 31, 2024 · 25 shares · 305 followers View post →
M. Fernanda Ramirez S. MD
@mframirezs1973 · X

RT @ZHeart11768530:

May 31, 2024 · 25 shares · 1,099 followers View post →
Gautam
@sharma14828 · X

RT @ZHeart11768530:

May 31, 2024 · 25 shares · 37,773 followers View post →
Sintayehu Abebe
@sinta_gf · X

RT @ZHeart11768530:

May 31, 2024 · 25 shares · 452 followers View post →
Mana
@manasigh · X

RT @ZHeart11768530:

May 31, 2024 · 25 shares · 331 followers View post →
Ros
@RosembergP33633 · X

RT @ZHeart11768530:

May 31, 2024 · 25 shares · 32 followers View post →
Prabhakar Dorairaj
@prabhud19 · X

RT @ZHeart11768530:

May 31, 2024 · 25 shares · 1,625 followers View post →
Nicolas Rodriguez Medina
@Nicolasrmedina · X

RT @ZHeart11768530:

May 31, 2024 · 25 shares · 20 followers View post →
Garnet
@GarnetGG · X

RT @ZHeart11768530:

May 31, 2024 · 25 shares · 140 followers View post →
The Heart
@ZHeart11768530 · X

May 31, 2024 · 84 likes · 25 shares · 32,814 followers View post →
JorgeEdoChava75
@QicenoJorge · X

RT @SABOURETCardio: Nice to see that "our contrarian view" has been cited in this article : Review of the #Ticagrelor Trials Evidence Base…

May 30, 2024 · 2 shares · 1,002 followers View post →
The Heart
@ZHeart11768530 · X

RT @SABOURETCardio: Nice to see that "our contrarian view" has been cited in this article : Review of the #Ticagrelor Trials Evidence Base…

May 30, 2024 · 2 shares · 32,814 followers View post →
SABOURETCardiologist
@SABOURETCardio · X

Nice to see that "our contrarian view" has been cited in this article : Review of the #Ticagrelor Trials Evidence Base | Journal of the American Heart Association https://t.co/GqtzjAjefi

May 30, 2024 · 11 likes · 2 shares · 31,172 followers View post →